Eric Shaff

Eric Shaff

Chief Executive Officer chez SERES THERAPEUTICS, INC.

Fortune : 104 738 $ au 31/07/2023

48 ans
Health Technology
Consumer Services
Finance

Provenance du réseau au premier degré de Eric Shaff

EntitéType d'entitéIndustrie
123
Subsidiary Medical Specialties 123
Public Company Biotechnology 37
Public Company Biotechnology 26
Subsidiary Pharmaceuticals: Major 4

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Eric Shaff via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Pharmaceuticals: Major

Robert Ruffolo

Thomas DesRosier

John Cox

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Paul Biondi

Paul Herbert Chew

Teresa Young

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

IMMUNOGEN, INC. Biotechnology

David B. Johnston

Mark Goldberg

Blaine McKee

Director of Finance/CFO

Director/Board Member

Corporate Officer/Principal

Medical Specialties

Stephen Oesterle

Victor J. Dzau

Arthur Coury

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

David Arkowitz

Richard Kender

Kurt Graves

Roger Pomerantz

John G. Aunins

David Ege

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

REPLIGEN CORPORATION Pharmaceuticals: Major

Hal Landy

John Cox

Konstantin Konstantinov

Corporate Officer/Principal

Director/Board Member

Director/Board Member

ARIAD PHARMACEUTICALS, INC. Biotechnology

Thomas DesRosier

Matthew P. Kowalsky

Jayne M. Gansler

Chief Administrative Officer

General Counsel

Human Resources Officer

BIOGEN INC. Pharmaceuticals: Major

Christopher Viehbacher

William Sibold

John Cox

Carlo Tanzi

Vanya Sagar

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Investor Relations Contact

Corporate Officer/Principal

AVANIR PHARMACEUTICALS INC Pharmaceuticals: Major

Thomas DesRosier

William Sibold

Brian Schiller

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

SANOFI Pharmaceuticals: Major

Thomas DesRosier

Christopher Viehbacher

William Sibold

Paul Herbert Chew

General Counsel

Chief Executive Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Medical Specialties

Thomas DesRosier

Michael W. Heslop

Matthew P. Kowalsky

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

RADIUS HEALTH, INC. Biotechnology

Michael Wyzga

Kurt Graves

Willard Dere

Chief Executive Officer

Chairman

Director/Board Member

Pharmaceuticals: Major

Meryl Zausner

Christine M. Granfield

Anne Altmeyer

Director of Finance/CFO

General Counsel

Corporate Officer/Principal

AURA BIOSCIENCES, INC. Biotechnology

Michael Wyzga

Henri A. Termeer

Peter Wirth

Julie Feder

Director of Finance/CFO

Director/Board Member

Director/Board Member

Director of Finance/CFO

Stanford University College/University

Robert Carpenter

Victor J. Dzau

Faraz Ali

Graduate Degree

Corporate Officer/Principal

Undergraduate Degree

Hospital/Nursing Management

Steven J. Burakoff

Mara Aspinall

Mark Goldberg

Director/Board Member

Director/Board Member

Corporate Officer/Principal

University of Pennsylvania College/University

Dennis Ausiello

Carlo Tanzi

David Ege

Doctorate Degree

Doctorate Degree

Doctorate Degree

Hospital/Nursing Management

Stephen Oesterle

Henri A. Termeer

Dennis Ausiello

Roger Pomerantz

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Noubar Afeyan

Douglas Cole

David Berry

Paul Biondi

Roger Pomerantz

Konstantin Konstantinov

Stephen Berenson

Marcus Chapman

Chief Executive Officer

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

Private Equity Investor

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Victor J. Dzau

Dennis Ausiello

Oved Amitay

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Henri A. Termeer

Noubar Afeyan

Paula Ragan

David Berry

Blaine McKee

John G. Aunins

James Streisand

Stephen Berenson

Martha Rook

Director/Board Member

Director/Board Member

Doctorate Degree

Doctorate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Boston College College/University

Joseph Lobacki

Richard F. Syron

Jason Amello

Joseph Reilly

Undergraduate Degree

Director/Board Member

Undergraduate Degree

Undergraduate Degree

Tufts University College/University

Richard F. Syron

Paula Ragan

Mara Aspinall

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Christopher Viehbacher

Oved Amitay

Nicholas Grund

Maria C. Mancini

Director/Board Member

Graduate Degree

Masters Business Admin

Graduate Degree

University of California, Berkeley College/University

David N. Cook

Matthew Henn

Qing Sarah Yuan

Doctorate Degree

Doctorate Degree

Undergraduate Degree

University of Massachusetts College/University

Daniel Paul Regan

Nicholas Grund

Jayne M. Gansler

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

University of Michigan College/University

David B. Johnston

John Cox

Brooke Story

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Henri A. Termeer

Christopher Viehbacher

Paul Herbert Chew

Director/Board Member

Chairman

Corporate Officer/Principal

Miscellaneous Commercial Services

Peter Hutt

Victor J. Dzau

Dennis Ausiello

Paul Herbert Chew

Corporate Officer/Principal

President

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Werner Cautreels

Christopher Viehbacher

Gregory Irace

Paul Herbert Chew

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Chief Executive Officer

Chief Tech/Sci/R&D Officer

AKEBIA THERAPEUTICS, INC. Pharmaceuticals: Major

Michael Wyzga

Victor J. Dzau

Jason Amello

Nicholas Grund

Kelly M. Brady

Director/Board Member

Director/Board Member

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Stephen Oesterle

Peter Hutt

Dennis Ausiello

Corporate Officer/Principal

Consultant / Advisor

Consultant / Advisor

Harvard Medical School College/University

Stephen Oesterle

Henri A. Termeer

Victor J. Dzau

Paula Ragan

Dennis Ausiello

David Berry

Mark Goldberg

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Graduate Degree

Doctorate Degree

Biotechnology

Henri A. Termeer

Robert Carpenter

Peter Hutt

Douglas Cole

Lorence Kim

Stephen Berenson

Director/Board Member

Director/Board Member

Director/Board Member

Founder

Director of Finance/CFO

Director/Board Member

VERASTEM, INC. Biotechnology

Joseph Lobacki

Henri A. Termeer

Julie Feder

Corporate Officer/Principal

Director/Board Member

Director of Finance/CFO

AXCA HEALPAR Biotechnology

Peter Hutt

Noubar Afeyan

Christopher Viehbacher

David Berry

Grégory Behar

Director/Board Member

Founder

Director/Board Member

Founder

Director/Board Member

Harvard Business School College/University

Robert Carpenter

Werner Cautreels

Glenn M. Reicin

Mara Aspinall

William Sibold

Faraz Ali

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Harvard College College/University

Stephen Oesterle

David N. Cook

Dennis Ausiello

Mark Goldberg

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

DICE THER Biotechnology

Philip Johnson

Michael Thompson

Chris Anderson

President

Director/Board Member

Corporate Secretary

EVELO BIOSCIENCES, INC. Pharmaceuticals: Major

Noubar Afeyan

David Berry

Roger Pomerantz

Founder

Founder

Director/Board Member

BIOVERATIV INC Biotechnology

William Sibold

John Cox

Rogério Vivaldi Coelho

Qing Sarah Yuan

President

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

MODERNA, INC. Biotechnology

Peter Hutt

Noubar Afeyan

Douglas Cole

Lorence Kim

Stephen Berenson

Director/Board Member

Founder

Founder

Director of Finance/CFO

Director/Board Member

X4 PHARMACEUTICALS, INC. Biotechnology

Michael Wyzga

Henri A. Termeer

Paula Ragan

Richard Peters

Chairman

Founder

Founder

Founder

Miscellaneous Commercial Services

Noubar Afeyan

Douglas Cole

John Cox

Stephen Berenson

Founder

Chairman

Chief Executive Officer

Director/Board Member

Biotechnology

Peter Hutt

Noubar Afeyan

David Berry

Director/Board Member

Director/Board Member

President

Statistiques

Internationale

Etats-Unis 50
France 2

Sectorielle

Health Technology 33
Consumer Services 12
Finance 4
Health Services 3
Commercial Services 3

Opérationnelle

Director/Board Member 653
Corporate Officer/Principal 282
Independent Dir/Board Member 173
Chairman 114
Founder 110
  1. Bourse
  2. Insiders
  3. Eric Shaff
  4. Connexions Sociétés